Balt Expands Irvine Operations, Reinforcing Long-Term U.S. Growth Strategy
Balt, a global neurovascular medical device company, is expanding its operations in Irvine with a second facility to support its U.S. growth strategy, planning over $400 million in investments and workforce growth to 1,200 employees by 2030. The expansion aims to enhance manufacturing, research, and innovation in stroke treatment technologies, further establishing Irvine as a hub for life sciences and advanced manufacturing.
Expansion expected to drive continued manufacturing, innovation, and high-skilled job growth in Irvine. IRVINE, Calif., May 19, 2026 /PRNewswire/ — Balt, a global neurovascular medical device company specializing in stroke treatment technologies, is continuing to expand its manufacturing…